PLATINOL-AQ: CISPLATIN INJECTION.
The CISPLATIN INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: VIAL, SINGLE DOSE, protective_storage_feature: ANTINEOPLASTIC DRUG, primary_container_content_quantity: 50.000 MILLILITERS, part_name_assigned_by_controlling_agency: PLATINOL-AQ. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-314-4270, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | VIAL, SINGLE DOSE |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| primary_container_content_quantity | 50.000 MILLILITERS |
| part_name_assigned_by_controlling_agency | PLATINOL-AQ |
| NSN | 6505-01-314-4270 |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| SPECIAL FEATURES | 50 MG CISPLATIN EQUIVALENT PREDILUTED IN 50 ML OF 0.9 PCT SODIUM CHLORIDE; STERILE; AQUEOUS; SINGLE-DOSE 50 ML FILL VIAL W/A RATED CAPACITY OF NOT LESS THAN 100 ML W/HANGING DEVICE WHICH ALLOWS THE BT TO BE HUNG FOR INTERMITTANT INTRAVENOUS ADMINISTRATION; FOR USE W/STOCKLISTED INTRAVENOUS INJECTION SETS |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PLATINOL-AQ |